Robin Harris, APN | |
501 N Galloway Rd, Lakeland, FL 33815-7241 | |
(816) 221-1024 | |
Not Available |
Full Name | Robin Harris |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 501 N Galloway Rd, Lakeland, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013936525 | NPI | - | NPPES |
8936145 | Medicaid | VA | |
3902158 | Medicaid | TN |
Entity Name | Wellmont Cardiology Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376575035 PECOS PAC ID: 5799970281 Enrollment ID: O20101215000083 |
News Archive
ImaginAb, Inc. a clinical-stage company developing in vivo imaging agents for Positron Emission Tomography (PET) based on antibody fragment technology, today announced the completion of a Series A financing – led by Novartis Venture Funds.
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).
A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.
Now, a new study by researchers at Yale School of Medicine and published on the preprint server medRxiv in September 2020 shows that pooled saliva samples can save resources and increase testing capacity, making a significant difference in the management of the pandemic.
Kids and young adults who drink no water throughout the day may consume twice the amount of calories from sugary drinks than those who drink water, according to Penn State researchers.
› Verified 9 days ago
Entity Name | Wellmont Medical Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780986257 PECOS PAC ID: 8123291739 Enrollment ID: O20111026000909 |
News Archive
ImaginAb, Inc. a clinical-stage company developing in vivo imaging agents for Positron Emission Tomography (PET) based on antibody fragment technology, today announced the completion of a Series A financing – led by Novartis Venture Funds.
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).
A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.
Now, a new study by researchers at Yale School of Medicine and published on the preprint server medRxiv in September 2020 shows that pooled saliva samples can save resources and increase testing capacity, making a significant difference in the management of the pandemic.
Kids and young adults who drink no water throughout the day may consume twice the amount of calories from sugary drinks than those who drink water, according to Penn State researchers.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Robin Harris, APN 501 N Galloway Rd, Lakeland, FL 33815-7241 Ph: (816) 221-1024 | Robin Harris, APN 501 N Galloway Rd, Lakeland, FL 33815-7241 Ph: (816) 221-1024 |
News Archive
ImaginAb, Inc. a clinical-stage company developing in vivo imaging agents for Positron Emission Tomography (PET) based on antibody fragment technology, today announced the completion of a Series A financing – led by Novartis Venture Funds.
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).
A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.
Now, a new study by researchers at Yale School of Medicine and published on the preprint server medRxiv in September 2020 shows that pooled saliva samples can save resources and increase testing capacity, making a significant difference in the management of the pandemic.
Kids and young adults who drink no water throughout the day may consume twice the amount of calories from sugary drinks than those who drink water, according to Penn State researchers.
› Verified 9 days ago
Adelene Soto, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 930 Marcum Rd, Lakeland, FL 33809 Phone: 863-815-3775 Fax: 863-815-3765 | |
Ana Lymaries Velez, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4715 S Florida Ave Ste 200, Lakeland, FL 33813 Phone: 863-209-7004 Fax: 863-607-3881 | |
Jennifer Frasier, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-607-9776 | |
Cheza Marie Wilkinson, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2849 Jennifer Dr, Lakeland, FL 33810 Phone: 863-899-1939 | |
Andrea Beale, A.R.N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-284-5020 Fax: 384-284-5387 | |
Reanna Renshaw, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5129 S Lakeland Dr Ste 2, Lakeland, FL 33813 Phone: 863-232-4323 Fax: 863-337-5728 | |
Anjali Nair, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 |